Azitra Inc (AZTR) Peer Comparison

$0.19

$-0.02 (-8.92%)

As on 27-Aug-2026 16:24EDT

Market cap

$8 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

6.6

P/B Ratio

0.3

Div. Yield

0 %

Edit

	Azitra Inc (AZTR)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Market cap ($ Mln)	8	2,920	2,195	914	839
Revenue ($ Mln)	--	450	549	--	366
Net Profit ($ Mln)	-12.27	-188.21	17.88	-175.85	9.27
Net Margin (%)	--	-41.86	3.26	--	2.53
RoE (%)	-220.43	-28.46	1.43	-106.84	3.39
Price to Earnings	6.64	--	126.30	--	84.64
Price-To-Book	0.28	4.82	1.73	5.59	3.06

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Azitra Inc (AZTR)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Operating Revenue	0.00	449.61	549.12	0.00	366.45
Cost of Revenue	0.34	195.71	548.01	12.78	49.36
Gross Profit	-0.45	269.08	212.72	-17.67	330.63
Operating Expenses	12.35	517.90	35.89	176.86	304.74
Operating Profit (EBIT)	-12.35	-264.00	-34.78	-181.14	12.35
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-12.26	-190.72	20.08	-178.93	15.84
Provision for Tax	0.01	-2.51	1.66	-3.09	6.57
Profit after Tax (Net Income)	-12.27	-188.21	17.88	-175.85	9.27
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Azitra Inc (AZTR)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Shareholder's Funds	7.33	607.04	1,260.78	160.40	270.49
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	0.05	39.17	186.25	8.50	104.25
Current Liabilities	1.53	428.58	275.21	54.30	93.25
Total Liabilities	5.03	1,172.38	1,753.10	233.72	499.81

Assets ($ Mln)

	Azitra Inc (AZTR)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Non-Current Assets	1.47	160.76	183.02	21.30	187.30
Current Assets	7.44	914.04	1,553.41	201.90	280.69
Total Assets	5.03	1,172.38	1,753.10	233.72	499.81
Total Debt*	0.41	254.58	94.51	21.00	113.30
Net Current Assets	0.00	485.45	0.00	147.60	187.44

Cashflow ($ Mln)

	Azitra Inc (AZTR)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Cash From Operating Activities	-11.22	-150.79	-64.66	-121.18	54.71
Cash Flow from Investing Activities	-0.18	307.87	-29.41	-1.37	26.25
Cash from Financing Activities	8.92	72.35	7.84	276.18	1.50
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Azitra Inc (AZTR)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
ROCE (%)	-209.13	-18.15	41.92	-130.25	0.77
ROE (%)	-220.43	-28.46	1.43	-106.84	3.39
ROA (%)	-112.76	-12.55	0.66	-74.77	1.69
EBIT Margin (%)	--	-41.09	-6.33	--	8.34
Net Margin (%)	--	-41.86	3.26	--	2.53
Cash Profit Margin (%)	--	0.00	--	--	0.00

Growth Ratios

	Azitra Inc (AZTR)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Revenue Growth (%)	-1.00	5.10	-8.81	-1.00	-99.61
EBIT Growth (%)	4.63	11.36	-76.55	-45.21	523.06
Net Profit Growth (%)	-31.12	11.44	-96.17	-43.04	-99.68
EPS Growth (%)	73.97	-1.87	-96.17	7.30	-96.78
Book Value Growth (%)	-58.33	-25.05	2.54	108.85	7.71

Valuation Ratios

	Azitra Inc (AZTR)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Price / Earnings	-0.12	-11.11	5.08	-9.99	469.58
Price / Book Value	0.34	2.73	1.88	8.70	4.83
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	0.03	-9.39	-25.58	-9.30	36.65
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Azitra Inc (AZTR)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Debt to Equity	0.00	0.00	0.00	0.00	0.34
Short term debt to equity ratio	0.05	0.40	0.02	0.09	0.03
Current Ratio	4.86	2.13	5.64	3.72	3.01
Quick Ratio	4.86	1.92	5.50	3.72	2.31
Interest Coverage	-1,155.82	-30.87	-19.05	--	2.08

Operating Efficiency Ratios

	Azitra Inc (AZTR)	Zai Lab - ADR	HUTCHMED (China) - ADR	DBV Technologies S.A. - ADR	Pharming Group N.V. ADS each representing 10 (PHAR)
Debtors to sales (%)	--	16.23	21.41	--	15.55
Asset Turnover	0.00	0.30	0.20	0.00	0.67
Receivable days	--	77.60	104.79	--	51.78
Inventory Days	--	109.55	49.57	--	492.02
Payable days	358.53	231.78	47.68	650.68	466.91
Cash Conversion Cycle	--	-44.63	106.67	--	76.89

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly